NCT06514261 2026-03-19
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
National Cancer Institute (NCI)
Phase 1 Recruiting
Clinical Trials
4 trialsNCT07113691 2026-02-17
TIARA
Yale University
Phase 1 Recruiting
NCT06357182 2025-08-12
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
OHSU Knight Cancer Institute
Phase 1 Recruiting
NCT05546580 2024-07-29
FRIDA
Oryzon Genomics S.A.
Phase 1 Recruiting